moomoo ID:0
Log Out
  • English
  • 中文繁体
  • 中文简体

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday

Benzinga Real-time News ·  09/13 17:16


  • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
  • InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 70.4% to close at $18.78 after the company on Friday announced a $6 million private placement priced at $8.68 per share.
  • Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares surged 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
  • PolyPid Ltd. (NASDAQ:PYPD) gained 58.3% to close at $1.71. The company earlier announced it will present Phase 2 D-PLEX100 data at the European Society for Coloproctology Scientific Conference next week.
  • Arqit Quantum Inc. (NASDAQ:ARQQ) shares gained 38.1% to close at $7.72. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today.
  • PaxMedica, Inc. (NASDAQ:PXMD) rose 36.6% to settle at $4.33 after TardiMed Sciences' Michael Derby on Friday disclosed a 63.4% active stake in the company.
  • Allego N.V. (NYSE:ALLG) jumped 33.5% to close at $5.90.
  • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) jumped 30.7% to close at $12.09. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma.
  • Clovis Oncology, Inc. (NASDAQ:CLVS) climbed 30.4% to close at $1.50 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with advanced ovarian cancer across disease risk subgroups.
  • Annovis Bio, Inc. (NYSE:ANVS) gained 29.5% to settle at $19.82 on above-average volume.
  • Kaspien Holdings Inc. (NASDAQ:KSPN) surged 27.7% to close at $2.86.
  • IHS Holding Limited (NYSE:IHS) jumped 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year.
  • Gogoro Inc. (NASDAQ:GGR) gained 21.3% to close at $5.25. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area.
  • ImmunityBio, Inc. (NASDAQ:IBRX) jumped 20.9% to close at $5.61.
  • POINT Biopharma Global Inc. (NASDAQ:PNT) rose 19.8% to close at $10.27 after the company published a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer.
  • Rackspace Technology, Inc. (NASDAQ:RXT) gained 18.8% to settle at $6.32.
  • Magic Empire Global Limited (NASDAQ:MEGL) jumped 17.9% to close at $6.00.
  • Regulus Therapeutics Inc. (NASDAQ:RGLS) rose 16.9% to close at $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile.
  • TuanChe Limited (NASDAQ:TC) gained 16.8% to close at $3.20.
  • Asana, Inc. (NYSE:ASAN) climbed 16.4% to close at $28.71. Asana's President, CEO and Director Dustin Moskovitz bought a total of 19,273,127 shares at an average price of $18.16.
  • Carvana Co. (NYSE:CVNA) gained 15.5% to close at $42.28. Piper Sandler upgraded Carvana from Neutral to Overweight and lowered the price target from $98 to $73.
  • Ra Medical Systems, Inc. (NYSE:RMED) surged 15.1% to close at $0.1675 after the company announced a merger agreement with Catheter Precision. Catheter Precision will become a wholly owned subsidiary of Ra Medical.
  • Finance Of America Companies Inc. (NYSE:FOA) gained 15.1% to settle at $1.60.
  • American Rebel Holdings, Inc. (NASDAQ:AREB) gained 14.7% to close at $0.6650.
  • American Rebel's CEO Andy Ross issued a corporate update in letter to stockholders.
  • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) jumped 13.6% to close at $26.46.
  • NIO Inc. (NYSE:NIO) surged 13.5% to close at $21.75 following positive analyst coverage from Deutsche Bank and BofA.
  • Vinco Ventures, Inc. (NASDAQ:BBIG) rose 13% to close at $1.13.
  • SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) gained 12.8% to close at $31.98 after the company announced data from the Phase 3 DeFi trial of nirogacestat in adult patients with desmoid tumors showed nirogacestat treatment resulted in rapid, sustained and statistically significant improvements in primary and all key secondary efficacy endpoints.
  • Cardlytics, Inc. (NASDAQ:CDLX) rose 12.2% to close at $14.31.
  • Auddia Inc. (NASDAQ:AUUD) gained 12% to settle at $1.40.
  • Sigma Lithium Corporation (NASDAQ:SGML) gained 11.4% to close at $27.81.
  • Ribbon Communications Inc. (NASDAQ:RBBN) jumped 10.5% to close at $3.57.
  • Quhuo Limited (NASDAQ:QH) shares gained 10.2% to close at $3.03 after the company on Friday said it has determined not to proceed with its proposed offering and sale of securities.
  • Lucid Group, Inc. (NASDAQ:LCID) jumped 9.7% to close at $16.55 after RF Lafferty initiated coverage on the stock with a Buy rating and a $19 price target.
  • NetScout Systems, Inc. (NASDAQ:NTCT) rose 9.4% to close at $33.60. The company, last month, posted upbeat quarterly earnings.
  • Reborn Coffee, Inc. (NASDAQ:REBN) rose 8.4% to close at $2.57. Dennis R Egidi recently reported a 9.5% stake in Reborn Coffee.
  • Wayfair Inc. (NYSE:W) gained 7.7% to settle at $55.95 amid overall market strength as investors await this week's inflation data.
  • Genenta Science S.p.A. (NASDAQ:GNTA) rose 7.5% to close at $5.15.
  • Hyperfine, Inc. (NASDAQ:HYPR) gained 7.4% to close at $1.31 after declining 6% on Friday. Hyperfine, last month, reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
  • Eve Holding, Inc. (NYSE:EVEX) gained 5.7% to close at $8.15. United recently announced a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
  • Bristol-Myers Squibb Company (NYSE:BMY) gained 3.1% to settle at $72.36. The FDA approved Bristol Myers Squibb Co's Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Atlantic Equities maintained Bristol-Myers Squibb with an Overweight and raised the price target from $83 to $87.


  • Tuesday Morning Corporation (NASDAQ:TUEM) dipped 31.2% to close at $0.1937. The company on Friday announced it has entered into an agreement to secure $32 million in convertible debt financing.
  • WeTrade Group, Inc. (NASDAQ:WETG) dropped 30.2% to close at $1.11 on above-average volume.
  • Akari Therapeutics, Plc (NASDAQ:AKTX) shares fell 27.9% to close at $0.75 on Monday after the company announced a $12.75 million registered direct offering.
  • Yoshiharu Global Co. (NASDAQ:YOSH) shares fell 26.9% to close at $3.05. The company, on Friday, priced its IPO at $4 per share.
  • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) fell 25.9% to close at $1.40. Ayala Pharmaceuticals presented interim data from RINGSIDE pivotal Phase 2/3 trial of AL102 show confirmed partial response in desmoid tumors, at ESMO Congress.
  • Intellinetics, Inc. (NASDAQ:INLX) dropped 22.9% to settle at $4.58 as the stock gave up last week's gains. The company recently announced an uplisting to the NYSE.
  • Goosehead Insurance, Inc (NASDAQ:GSHD) fell 21.9% to close at $42.28. Goosehead Insurance named Mark Jones, Jr as new CFO.
  • ShiftPixy, Inc. (NASDAQ:PIXY) declined 20.8% to close at $27.28 amid profit taking after the stock surged last week following the company's announcement it plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
  • Entrada Therapeutics, Inc. (NASDAQ:TRDA) fell 20.2% to close at $11.91. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
  • Leap Therapeutics, Inc. (NASDAQ:LPTX) fell 20.1% to close at $1.35.
  • DICE Therapeutics, Inc. (NASDAQ:DICE) fell 16.5% to close at $18.91. Stifel, last week, initiated coverage on the stock with a Buy rating and a $37 price target.
  • Immatics N.V. (NASDAQ:IMTX) fell 15.2% to close at $10.90.
  • Great Panther Mining Limited (NYSE:GPL) declined 14.1% to close at $0.2028.
  • United-Guardian, Inc. (NASDAQ:UG) fell 12.9% to settle at $12.82. United-Guardian, last month, posted Q2 EPS of $0.14.
  • AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) declined 12.8% to close at $0.1767.
  • T Stamp Inc. (NASDAQ:IDAI) dropped 12.4% to close at $1.55.
  • Nuwellis, Inc. (NASDAQ:NUWE) fell 11.2% to close at $0.7547.
  • Sarcos Technology and Robotics Corporation (NASDAQ:STRC) fell 11% to settle at $3.47.
  • Vertex Energy, Inc. (NASDAQ:VTNR) fell 9.9% to close at $7.83. Vertex Energy announced extension of Mobile Refinery's mechanical completion target to first quarter of 2023.
  • Lesaka Technologies, Inc. (NASDAQ:LSAK) dipped 9.3% to settle at $4.69.
  • MOGU Inc. (NYSE:MOGU) dropped 9.2% to close at $2.36. Mogu's board of directors, on Friday, authorized a new share repurchase program of up to $10 million of its shares.
  • Apexigen, Inc. (NASDAQ:APGN) fell 8.7% to close at $6.95 as the company announced the presentation of new data from a Phase 2 trial evaluating sotigalimab (sotiga) in combination with neoadjuvant chemoradiation for resectable esophageal and gastroesophageal junction (GEJ) cancers.
  • CleanTech Acquisition Corp. (NASDAQ:CLAQ) fell 8.2% to close at $5.60. CleanTech Acquisition and Nauticus Robotics completed business combination to trade under "KITT" effective September 13.
  • Intrepid Potash, Inc. (NYSE:IPI) dropped 8.2% to settle at $43.09.
  • Codere Online Luxembourg, S.A. (NASDAQ:CDRO) fell 6.3% to close at $3.00. Codere Online recently reported Q2 sales results.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites and Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.